dRTA in SS may result from autoimmune targeting of distal nephron transporters such as H+-ATPase and anion exchanger 1. Early recognition and supportive treatment are essential to prevent complications including nephrolithiasis, progressive kidney dysfunction, and life-threatening hypokalemia. This evidence concerns the gene SLC4A1 and synovial sarcoma.